$17 discrepancies? Are you for real? Where is, like, your...

First 23 Last

Share
Profile

Follow
Ozjin

998 Posts.

153

30/01/20

19:26

Post #: 42653878
Share

Originally posted by Dentie ↑

I most certainly don’t want to upset the apple carts but (as a long term holder & "hoper" and at the risk of getting a kicking)... I think announcing these figures to the market was not a good move. Apart from being “unsigned” by the CEO, the numbers are inaccurate and may give some prospective & existing shareholders a distorted picture.

As usual, the narrative is typically upbeat & positive sounding - which is obviously what we want to see, but to me, and I am very happy to be corrected on this, there is a lack of narrative explaining why most of the operating cost numbers don’t add up, as follows:
·There appears to be a $70 discrepancy in the R&D Costs from Q12020
·There appears to be a $743 hole in the Production Manufacturing Costs from Q12020
·There appears to be a $56 discrepancy in the Advertising Costs from Q12020
·There appears to be a $17 discrepancy in the Advertising Costs from Q12020
·There appears to be a $887 hole in the Admin & Corporate Costs from Q12020

Whether they have just announced a draft copy, or they haven’t checked the numbers I don’t know – but to me, this is no excuse and is not good enough. Here’s my other thoughts…
·Admin Costs – 61% increase compared to Q22019
·Net cash position is worse than Q22019 (& that included the the Ikon debacle payment) as well as the issuance of more share capital last year
·Overall, there was an average 57% increase of actual cash expenditure from what was estimated in Q12020 (including a 217% over estimation in the Admin Costs alone)

Overall, I was underwhelmed and I am hoping like hell the above was just an unfortunate error – or that I am looking at the wrong 4C!

Expand

$17 discrepancies? Are you for real? Where is, like, your evidence?

CDY Price at posting: 21.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

CBA breaks trading record on strong day for Aussie financials

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

There are more pages in this discussion • 51 more messages in this thread...

First 23 Last

Add AN1 (ASX) to my watchlist

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $3.690M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

$17 discrepancies? Are you for real? Where is, like, your...

Shekel Brainweigh investor presentation webinar – the future of retail automation

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Red Mountain Mining: record gold prices, two projects, two greenstone belts

CBA breaks trading record on strong day for Aussie financials

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Featured News

Featured News

$17 discrepancies? Are you for real? Where is, like, your...

Top Stories

Shekel Brainweigh investor presentation webinar – the future of retail automation

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Red Mountain Mining: record gold prices, two projects, two greenstone belts

CBA breaks trading record on strong day for Aussie financials

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Featured News

Featured News